对皮质类固醇依赖的瘤型麻风患者持续性麻风结节性红斑的一种治疗方法。G.30320（B663）的临床评估。 - Suppr

Suppr

超能文献

A treatment of corticosteroid-dependent lepromatous patients in persistent erythema nodosum leprosum. A clinical evaluation of G.30320 (B663).

作者信息

Imkamp F M

出版信息

Lepr Rev. 1968 Jul;39(3):119-25. doi: 10.5935/0305-7518.19680022.

DOI:10.5935/0305-7518.19680022

PMID:4298736

Abstract

摘要

相似文献

A treatment of corticosteroid-dependent lepromatous patients in persistent erythema nodosum leprosum. A clinical evaluation of G.30320 (B663).

Lepr Rev. 1968 Jul;39(3):119-25. doi: 10.5935/0305-7518.19680022.

The treatment of erythema nodosum leprosum with B.663. A controlled study.

Int J Lepr Other Mycobact Dis. 1967 Jan-Mar;35(1):11-6.

The treatment of corticosteroid-dependent lepromatous patients in persistent Erythema nodosum leprosum with clofazimine.

Lepr Rev. 1973 Sep;44(3):127-30.

Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy.

Dermatol Int. 1969 Jan-Mar;8(1):21-7. doi: 10.1111/j.1365-4362.1969.tb05324.x.

Localized and persistent erythema nodosum leprosum - a rare variant?

Dermatol Online J. 2008 Mar 15;14(3):16.

Erythema nodosum leprosum.

Int J Lepr Other Mycobact Dis. 1967 Jul-Sep;35(3):400-1.

Treatment of moderately severe erythema nodosum leprosum with clofazimine--a controlled trial.

Lepr Rev. 1971 Sep;42(3):167-77. doi: 10.5935/0305-7518.19710020.

Controlled clinical trial of clofazimine in untreated lepromatous leprosy.

Br Med J. 1971 Nov 27;4(5786):514-6. doi: 10.1136/bmj.4.5786.514.

Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.

Int J Lepr Other Mycobact Dis. 1967 Jul-Sep;35(3):311-35.

Erythema nodosum leprosum.

Int J Lepr Other Mycobact Dis. 1967 Jul-Sep;35(3):397-8.

引用本文的文献

Synthesis of new riminophenazines with pyrimidine and pyrazine substitution at the 2-N position.

Molecules. 2011 Aug 16;16(8):6985-91. doi: 10.3390/molecules16086985.

Interventions for erythema nodosum leprosum.

Cochrane Database Syst Rev. 2009 Jul 8;2009(3):CD006949. doi: 10.1002/14651858.CD006949.pub2.

Effects of clofazimine alone or combined with dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy.

Antimicrob Agents Chemother. 1982 May;21(5):693-7. doi: 10.1128/AAC.21.5.693.

New drug for leprosy.

Br Med J. 1969 Mar 29;1(5647):797-8.

A study of clofazimine in the rat.

Br J Pharmacol. 1972 Aug;45(4):676-81. doi: 10.1111/j.1476-5381.1972.tb08126.x.

Double-blind controlled clinical trial of clofazimine in reactive phases of lepromatous leprosy.

Br Med J. 1970 Jan 24;1(5690):198-200. doi: 10.1136/bmj.1.5690.198.

Enhancement by clofazimine and inhibition by dapsone of production of prostaglandin E2 by human polymorphonuclear leukocytes in vitro.

Antimicrob Agents Chemother. 1985 Feb;27(2):257-62. doi: 10.1128/AAC.27.2.257.

Structure-activity relationships of selected phenazines against Mycobacterium leprae in vitro.

Antimicrob Agents Chemother. 1988 Oct;32(10):1583-5. doi: 10.1128/AAC.32.10.1583.

Antimicrobial activities of clofazimine and B669 are mediated by lysophospholipids.

Antimicrob Agents Chemother. 1992 Dec;36(12):2729-35. doi: 10.1128/AAC.36.12.2729.

Corneal changes in patients treated with clofazimine.

Br J Ophthalmol. 1976 Jul;60(7):526-8. doi: 10.1136/bjo.60.7.526.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验